A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

  • STATUS
    Recruiting
  • End date
    Apr 30, 2021
  • participants needed
    2450
  • sponsor
    Eli Lilly and Company
Send
Updated on 18 January 2021
See if I qualify
Investigator
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Primary Contact
Infect Disease Doctors Med Grp (4.7 mi away) Contact
+167 other location
fever
myalgia
dyspnea
covid-19
cough
pharyngitis
headache
sore throat

Summary

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.

Details
Treatment Placebo, LY3819253, LY3832479
Clinical Study IdentifierNCT04427501
SponsorEli Lilly and Company
Last Modified on18 January 2021

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

 Yes No Not Sure

Inclusion Criteria

Do you have any of these conditions: *COVID-19 or Covid-19?
Do you have any of these conditions: Covid-19 or *COVID-19?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: *COVID-19 or Covid-19?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: *COVID-19 or Covid-19?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: Covid-19 or *COVID-19?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: *COVID-19 or Covid-19?
Is your age greater than or equal to 12 yrs?
Is your age greater than or equal to 18 yrs?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: *COVID-19 or Covid-19?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: *COVID-19 or Covid-19?
Is your age greater than or equal to 12 yrs?
Is your age greater than or equal to 12 yrs?
Is your age greater than or equal to 12 yrs?
Do you have any of these conditions: Covid-19 or *COVID-19?
Gender: Male or Female
Are currently not hospitalized
Have one or more mild or moderate COVID-19 symptoms: Fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, or shortness of breath with exertion
Must have sample taken for test confirming viral infection no more than 3 days prior to starting the drug infusion
Are males or non-pregnant females who agree to contraceptive requirements
Understand and agree to comply with planned study procedures
Agree to the collection of nasopharyngeal swabs and venous blood
The participant or legally authorized representative give signed informed consent and/or assent
Participants in treatment arms 7 and 8 ONLY
Are greater than or equal to ()18 years of age and must satisfy at least one of the following at the time of screening
Are 65 years of age
Have a body mass index (BMI) 35
Have chronic kidney disease (CKD)
Have type 1 or type 2 diabetes
Have immunosuppressive disease
Are currently receiving immunosuppressive treatment or
Are 55 years of age AND have
cardiovascular disease (CVD), OR
hypertension, OR
chronic obstructive pulmonary disease (COPD) or other chronic respiratory disease
Are 12-17 years of age (inclusive) AND satisfy at least one of the following at the time of screening
Have a body mass index (BMI) 85th percentile for their age and gender based on CDC growth charts, <https://www.cdc.gov/growthcharts/clinical_charts.htm>
Have sickle cell disease
Have congenital or acquired heart disease
Have neurodevelopmental disorders, for example, cerebral palsy
Have a medical-related technological dependence, for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19)
Have asthma or reactive airway or other chronic respiratory disease
Have type 1 or type 2 diabetes
Have immunosuppressive disease, or
Have chronic kidney disease
Are currently receiving immunosuppressive treatment

Exclusion Criteria

Have oxygen saturation (SpO2) less than or equal to ()93 percent (%) on room air at sea level or ratio of arterial oxygen partial pressure (PaO2 in millimeters of mercury) to fractional inspired oxygen (FiO2) less than (<)300, respiratory rate greater than or equal to ()30 per minute, heart rate 125 per minute
Require mechanical ventilation or anticipated impending need for mechanical ventilation
Have known allergies to any of the components used in the formulation of the interventions
Have hemodynamic instability requiring use of pressors within 24 hours of randomization
Suspected or proven serious, active bacterial, fungal, viral, or other infection (besides COVID-19) that in the opinion of the investigator could constitute a risk when taking intervention
Have any co-morbidity requiring surgery within <7 days, or that is considered life-threatening within 29 days
Have any serious concomitant systemic disease, condition or disorder that, in the opinion of the investigator, should preclude participation in this study
Have a history of a positive SARS-CoV-2 test prior to the one serving as eligibility for this study
Have received an investigational intervention for SARS-CoV-2 prophylaxis within 30 days before dosing
Have received treatment with a SARS-CoV-2 specific monoclonal antibody
Have a history of convalescent COVID-19 plasma treatment
Have participated in a previous SARS-CoV-2 vaccine study
Have participated, within the last 30 days, in a clinical study involving an investigational intervention. If the previous investigational intervention has a long half-life, 5 half-lives or 30 days, whichever is longer, should have passed
Are concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study
Are pregnant or breast feeding
Have body weight <40 kilograms (kg)
Clear my responses
Read more

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name
Edit Delete

Annotated by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet